Drug Shortage Report for MYLAN-MIRTAZAPINE

Last updated on 2020-02-20 History
Report ID 104515
Drug Identification Number 02256126
Brand name MYLAN-MIRTAZAPINE
Common or Proper name MIRTAZAPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) MIRTAZAPINE
Strength(s) 45MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-01-22
Estimated end date 2020-02-18
Actual end date 2020-02-19
Shortage status Resolved
Updated date 2020-02-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-02-20 English Compare
v4 2020-02-19 French Compare
v3 2020-02-19 English Compare
v2 2020-01-28 French Compare
v1 2020-01-28 English Compare

Showing 1 to 5 of 5